Zimmer Biomet Holdings Inc ZBH
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2026 Financial Results
-
Zimmer Biomet Announces Americas Leadership Promotions to Accelerate Commercial Transformation
-
Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2026
-
Zimmer Biomet Announces Second Quarter 2026 Financial Results
-
Zimmer Biomet Names Chintan Desai President of Asia Pacific Region
-
Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2026 Financial Results
Trading Information
- Previous Close Price
- CHF 62.50
- Day Range
- CHF 77.50–77.50
- 52-Week Range
- CHF 62.50–81.50
- Bid/Ask
- CHF 73.50 / CHF 74.50
- Shares Outstanding
- 190.74M
- Market Cap
- $14.78B
- Volume/Avg
- 34 / 34
Key Statistics
- Price/Earnings (Normalized)
- 10.92
- Price/Sales
- 2.14
- Dividend Yield (Trailing)
- 1.04%
- Dividend Yield (Forward)
- 1.09%
- Dividend Payment Schedule
- Jan, Apr, Jul, Oct
- Total Yield
- 5.26%
Company Profile
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Mid Value
- Total Number of Employees
- 17,000
- Website
- https://www.zimmerbiomet.com
Competitors
Valuation
|
Metric
|
ZBH
|
SNN
|
SYK
|
|---|---|---|---|
Price/Earnings (Normalized) | 10.92 | 13.93 | 19.85 |
Price/Book Value | 1.37 | 2.20 | 4.43 |
Price/Sales | 2.14 | 1.85 | 4.14 |
Price/Cash Flow | 9.44 | 9.47 | 18.96 |
Price/Earnings
ZBH
SNN
SYK
Financial Strength
|
Metric
|
ZBH
|
SNN
|
SYK
|
|---|---|---|---|
Quick Ratio | 0.72 | 1.11 | 1.08 |
Current Ratio | 1.69 | 2.14 | 2.16 |
Interest Coverage | 4.23 | 5.42 | — |
Quick Ratio
ZBH
SNN
SYK
Profitability
|
Metric
|
ZBH
|
SNN
|
SYK
|
|---|---|---|---|
Return on Assets (Normalized) | 7.24% | 8.51% | 11.44% |
Return on Equity (Normalized) | 13.16% | 17.09% | 23.97% |
Return on Invested Capital (Normalized) | 9.44% | 11.66% | 14.10% |
Return on Assets
ZBH
SNN
SYK
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|l%bcYR | LOCK|w^#ZH | $170B | |||
| Medtronic PLC
MDT
| LOCK|mXlFw@j | LOCK|g$x^@ | $112B | |||
| Stryker Corp
SYK
| LOCK|KgcCqlFl | LOCK|!t | $106B | |||
| Boston Scientific Corp
BSX
| LOCK|FPrRj# | LOCK|b%L@h | $61B | |||
| Edwards Lifesciences Corp
EW
| LOCK|LnWVJ!Hm | LOCK|fHL#> | $49B | |||
| DexCom Inc
DXCM
| LOCK|JK#V^^YS | LOCK|#c?#@ | $32B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|$KwTzw | LOCK|%%Z | $29B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|Sz | LOCK|Jl | $24B | |||
| Steris PLC
STE
| LOCK|L>^k@< | LOCK|$#<n# | $21B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|QZ%^dtR | LOCK|q# | $17B |
United States